Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 0 | 0 | 126,576 | 12,375 | 379 |
| Gross Profit | N/A | N/A | 126,576 | 12,375 | 379 |
| Operating Expenses | 37,724 | 36,858 | 30,827 | 32,407 | 22,713 |
| Operating Income | -37,724 | -36,858 | 95,749 | -20,032 | -22,334 |
| Interest Expense | 695 | 651 | -7 | 649 | 634 |
| Other Income | 847 | 340 | 442 | 42 | 58 |
| Pre-tax Income | -37,572 | -37,169 | 96,198 | -20,639 | -22,910 |
| Net Income Continuous | -37,572 | -37,169 | 96,198 | -20,639 | -22,910 |
| Net Income | $-37,572 | $-37,169 | $96,198 | $-20,639 | $-22,910 |
| EPS Basic Total Ops | -0.62 | -0.63 | 1.86 | -0.40 | -0.44 |
| EPS Basic Continuous Ops | -0.62 | -0.63 | 1.86 | -0.40 | -0.44 |
| EPS Diluted Total Ops | -0.62 | -0.63 | 1.84 | -0.40 | -0.44 |
| EPS Diluted Continuous Ops | -0.62 | -0.63 | 1.84 | -0.40 | -0.44 |
| EBITDA(a) | $-37,980 | $-36,900 | $95,930 | $-19,851 | $-22,138 |